 |
Viatris
VTRS
|
$ 13.44
|
16.1 B
|
$ 172 M
|
-4.7
|
1.1
|
$ -2.8
|
 |
 |
Tilray
TLRY
|
$ 6.43
|
3.97 B
|
$ -105 M
|
-2.8
|
4.8
|
$ -2.3
|
 |
 |
Bausch Health Companies
BHC
|
$ 4.97
|
1.81 B
|
$ 3.23 B
|
-4.6
|
0.2
|
$ -1.1
|
 |
 |
Perrigo Company plc
PRGO
|
$ 9.74
|
1.35 B
|
$ 579 M
|
-45.6
|
0.3
|
$ -0.2
|
 |
 |
Cronos Group
CRON
|
$ 2.54
|
1.33 B
|
∙ |
∙ |
∙ |
∙ |
 |
 |
Harrow Health
HROW
|
$ 35.35
|
1.3 B
|
$ 17.6 M
|
-75.6
|
5.4
|
$ -0.4
|
 |
 |
Pacira BioSciences
PCRX
|
$ 22.73
|
1.05 B
|
$ -75.6 M
|
-7.6
|
1.5
|
$ -3.0
|
 |
 |
Solid Biosciences
SLDB
|
$ 6.79
|
594 M
|
$ -115 M
|
-3.1
|
31.7
|
$ -2.3
|
 |
 |
Emergent BioSolutions
EBS
|
$ 8.03
|
411 M
|
$ -238 M
|
-1.1
|
0.4
|
$ -7.5
|
 |
 |
Organogenesis Holdings
ORGO
|
$ 2.4
|
316 M
|
$ 2.42 M
|
-35.3
|
0.7
|
$ -0.1
|
 |
 |
Veru
VERU
|
$ 2.3
|
310 M
|
$ -31.2 M
|
-1.6
|
22.9
|
$ -1.4
|
 |
 |
Evolus
EOLS
|
$ 4.62
|
298 M
|
$ -48.4 M
|
-4.2
|
1.1
|
$ -1.1
|
 |
 |
Relmada Therapeutics
RLMD
|
$ 6.08
|
240 M
|
$ -165 M
|
-3.1
|
-216.0
|
$ -1.9
|
 |
 |
Assertio Holdings
ASRT
|
$ 16.05
|
103 M
|
$ -3.27 M
|
-63.6
|
0.7
|
$ -0.2
|
 |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 3.17
|
44.6 M
|
$ 1.01 M
|
-14.5
|
1.1
|
$ -0.2
|
 |
 |
SCYNEXIS
SCYX
|
$ 0.87
|
43.4 M
|
$ -72.9 M
|
-1.8
|
16.8
|
$ -0.5
|
 |
 |
Rockwell Medical
RMTI
|
$ 1.05
|
24.5 M
|
$ 1.12 M
|
-25.5
|
0.3
|
$ -0.0
|
 |
 |
TherapeuticsMD
TXMD
|
$ 2.29
|
23.9 M
|
$ -3.18 M
|
-46.2
|
9.0
|
$ -0.0
|
 |
 |
China Pharma Holdings
CPHI
|
$ 0.63
|
11 M
|
$ -1.98 M
|
-0.5
|
2.7
|
$ -1.2
|
 |
 |
cbdMD
YCBD
|
$ 0.77
|
3.32 M
|
$ -1.22 M
|
-0.2
|
0.2
|
$ -3.9
|
 |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 2.34
|
2.9 M
|
$ -5.22 M
|
-1.2
|
0.2
|
$ -2.2
|
 |